Financial

News

Sanofi spin-off EuroAPI slumps as revenues falter

Shares in EuroAPI, the active pharmaceutical ingredients (API) business spun out of Sanofi last year, have fallen sharply on the back of a sharp slowdown in sales.

News

Novartis updates on Sandoz finances ahead of spin-off

Novartis confirmed this morning that it expects to complete the separation of its generic and biosimilar medicines unit Sandoz into an independent company on or around 4th

News

Mallinckrodt looking at a second bankruptcy filing

Mallinckrodt is facing the prospect of a second bankruptcy filing in the space of three years, as it struggles to get its business back on track and meet the requirement o

News

Babylon closes US business as rescue merger deal fails

Babylon Health's efforts to raise financing to steady its business have been scuppered by the collapse of a proposed merger with digital therapeutics firm MindMaze, which

News

Novo Nordisk buys Inversago for $1bn as Wegovy sales soar

Sales of its obesity therapies may be accelerating, but Novo Nordisk is showing no signs of pushing the brake pedal on investments in the category.

News

Novavax swings to profit as it preps new COVID jab launch

Just a few months after suggesting it may not survive to the end of 2023, Novavax has posted improved finances and a second-quarter profit, as it readies the launch of an

Sanofi spin-off EuroAPI slumps as revenues falter

Novartis updates on Sandoz finances ahead of spin-off

Mallinckrodt looking at a second bankruptcy filing

Babylon closes US business as rescue merger deal fails

Novo Nordisk buys Inversago for $1bn as Wegovy sales soar

Novavax swings to profit as it preps new COVID jab launch

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

Financial

Editor's Picks